Germany - medicaments
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 31 December 2020
- Opportunity publication date
- 22 November 2018
- Category
- 33600000
- Value of contract
- to be confirmed
- Your guide to exporting
Description
The participating health insurance funds pursue the goal of concluding discount agreements with all suitable pharmaceutical companies for the active substance baricitinib in accordance with §§ 130a Para. 8 and 130c Para. 1 SGB V.
The contract is concluded within the framework of the open-house procedure of the health insurance funds:
Individual negotiations about contract contents are not conducted, uniform conditions apply. The health insurance funds do not guarantee exclusivity to individual contractual partners. The contract period shall be a maximum of 24 months starting on 1.1.2019. The contract shall end on 31.12.2020 at the latest, irrespective of the date of conclusion of the contract. Joining this open-house procedure is possible at any time during the contract period. All further information can be found in the participation and contract documents. If the patent expires before 31.12.2020, the contract automatically expires at the end of the month in which the patent expires.
- Opportunity closing date
- 31 December 2020
- Value of contract
- to be confirmed
About the buyer
- Address
- Techniker Krankenkasse Bramfelder Str. 140 Hamburg 22305 Germany
- Contact
- dzem@tk.de
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.